We are live on ! Find out more
BIOA icon

BioAge Labs

83 hedge funds and large institutions have $85.6M invested in BioAge Labs in 2025 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 31 increasing their positions, 9 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

244% more repeat investments, than reductions

Existing positions increased: 31 | Existing positions reduced: 9

167% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 9

24% more funds holding

Funds holding: 67 → 83 (+16)

17% more capital inflows, than outflows

Capital inflows: $18.3M | Capital outflows: $15.6M

1.22% more ownership

Funds ownership: 56.57% → 57.79% (+1.2%)

20% less funds holding in top 10

Funds holding in top 10: 5 → 4 (-1)

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $1.26M

Holders
83
Holders Change
+16
Holders Change %
+23.88%
% of All Funds
1.09%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.05%
New
24
Increased
31
Reduced
9
Closed
9
Calls
–
Puts
$1.26​M
Net Calls
-⁠$1.26​M
Net Calls Change
-⁠$496​K

BIOA Hedge Fund Activity: Q2 2025 in Review

83 of the 7,630 institutional investors tracked by Wall St. Rank reported a position in BioAge Labs (BIOA) for Q2 2025, worth a combined $85.6M — up 12% from $76.2M a quarter earlier.

Buyers outnumbered sellers: 24 funds opened new BIOA positions and 9 closed out — a net gain of 15 holders — while 31 added to existing stakes and 9 trimmed.

The largest buyer was ADAR1 Capital Management, adding an estimated $3.89M. The largest seller was Suvretta Capital Management, exiting entirely with an estimated $5.46M sold.

  • 83 institutional investors held BioAge Labs (BIOA) as of Q2 2025, up from 67 in Q1 2025.
  • Funds reported $85.6M of BioAge Labs stock for Q2 2025, up 12% quarter-over-quarter.
  • 24 funds opened new BioAge Labs positions in Q2 2025 and 9 closed out, a net change of +15 holders.
  • The largest BioAge Labs buyer in Q2 2025 was ADAR1 Capital Management, an estimated $3.89M added.
  • The largest BioAge Labs seller in Q2 2025 was Suvretta Capital Management, an estimated $5.46M sold.

Based on aggregated 13F filings for Q2 2025.